Reviva Pharmaceuticals

/Reviva Pharmaceuticals

Follow-on

Reviva Pharmaceuticals

Biopharmaceutical

We are a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. Our current pipeline focuses on the central nervous system, respiratory, and metabolic diseases.

Symbol

RVPH

Last Closing Price
$5.44

Shares
4,000,000

Anticipated Date
May 27, 2021

Underwriters
MAXIM GROUP LLC

This offering is no longer available

To view the prospectus for Reviva Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange